Anixa Biosciences's market cap is currently $141.21M. The company's EPS TTM is $-0.389; its P/E ratio is ―; Anixa Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
